2013 International Expert Meeting on Congenital Melanocytic Nevi (CMN) and Neuroc

描述（由申请人提供）：近年来，在了解大型先天性黑色素细胞痣（LCMN）的起源和临床治疗方面取得了相当大的进展。来自遗传学、细胞生物学、流行病学和治疗研究的新成果，伴随着由美国和欧洲国家的团体牵头的世界各地患者倡议所做的巨大努力。所有这些行为者之间存在着巨大的协同潜力。2011年在德国T bingen举行的国际专家会议使基础生物学和临床医学领域的杰出研究人员能够交流最新的，有时是未发表的信息。2013年在法国马赛举行的国际专家会议将促进和促成与会者之间新型、跨学科和国际合作的协调。美国和欧洲主要LCMN倡导团体的领导将出席会议，以进一步完善2011年建立的国际倡议。这些结果将继续为改善这种毁容和可能危及生命的疾病患者的诊断和治疗做出重要贡献。

DESCRIPTION (provided by applicant): In recent years, considerable progress has been made in understanding the origins and clinical management of large congenital melanocytic nevi (LCMN). New results from genetics, cell biology, epidemiology, and therapeutic research are flanked by enormous efforts made by patient initiatives around the world, spearheaded by groups in the U.S. and European countries. There is enormous potential for synergy between all of these players. The 2011 International Expert Meeting in T¿bingen, Germany enabled the exchange of the most up-to-date, sometimes unpublished information from basic biology and clinical medicine among outstanding researchers in the field. This 2013 International Expert Meeting in Marseille, France will foster and enable the coordination of novel, interdisciplinary and international collaborations among participants. The leadership of major U.S. and European LCMN advocacy groups will attend the conference, to further refine the international initiatives established in 2011. These outcomes will continue making important contributions to the improvement of diagnosis and treatment for patients with this disfiguring and potentially life-threatening disease.